Penrhos Bio
PrivateLast Round
Series A
Oct 31, 2023
Total Funding Raised
$4.78M
Company Overview
Penrhos Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in October 2023.
Penrhos Bio is a biotechnology company that develops and commercializes sustainable anti-biofilm technology inspired by nature.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Sustainable Materials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Penrhos Bio Comparables
Compare Penrhos Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aequor Inc. | 80% | |
| Sharklet Technologies | 78% | |
| Pylote | 77% |
For institutional investors. Book with your work email.
Penrhos Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2023 | ||||
| Seed | Sep 5, 2022 |
For institutional investors. Book with your work email.
Penrhos Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orchard Ventures | Series A |
| Eos Advisory | Series A, Seed |
| Scottish Investment Bank (Scottish Enterprise) | Series A |
| Innova Partnerships | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 230% MoM, reaching 2.6K.
- Sep 28, 2024
Grew 50% QoQ from 8 to 12 employees.
For institutional investors. Book with your work email.
Penrhos Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Penrhos Bio's valuation, stock price, and market status.
Is Penrhos Bio a public or private company?
Penrhos Bio is a private company.
What is the current stock price of Penrhos Bio?
Penrhos Bio is a private company, so its shares have no public market price. Caplight tracks Penrhos Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Penrhos Bio worth (valuation)?
Valuation information for Penrhos Bio is not publicly available.
Can I buy Penrhos Bio stock?
Penrhos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Penrhos Bio's last funding round?
Penrhos Bio's most recent funding round was Series A on October 31, 2023.
Who are the main investors in Penrhos Bio?
Key investors in Penrhos Bio include Eos Advisory, Scottish Investment Bank (Scottish Enterprise).
Will Penrhos Bio IPO soon?
No public IPO plans have been announced for Penrhos Bio.
How can I track Penrhos Bio secondary market activity?
Caplight tracks bids, offers, and trades in Penrhos Bio's shares on secondary markets.